annual SGA:
$0.00-$52.79M(-100.00%)Summary
- As of today (September 14, 2025), LGND annual SGA is $0.00, with the most recent change of -$52.79 million (-100.00%) on December 31, 2024.
- During the last 3 years, LGND annual SGA has fallen by -$46.79 million (-100.00%).
- LGND annual SGA is now -100.00% below its all-time high of $113.00 million, reached on December 31, 2006.
Performance
LGND SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$0.00-$18.80M(-100.00%)Summary
- As of today (September 14, 2025), LGND quarterly SGA is $0.00, with the most recent change of -$18.80 million (-100.00%) on June 30, 2025.
- Over the past year, LGND quarterly SGA has dropped by -$17.62 million (-100.00%).
- LGND quarterly SGA is now -100.00% below its all-time high of $35.71 million, reached on June 30, 2006.
Performance
LGND quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$1.95B-$75.86M(-3.75%)Summary
- As of today (September 14, 2025), LGND TTM SGA is $1.95 billion, with the most recent change of -$75.86 million (-3.75%) on June 30, 2025.
- Over the past year, LGND TTM SGA has increased by +$1.89 billion (+3187.58%).
- LGND TTM SGA is now -9.84% below its all-time high of $2.16 billion.
Performance
LGND TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
LGND Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | +3187.6% |
| 3 y3 years | -100.0% | -100.0% | +3847.2% |
| 5 y5 years | -100.0% | -100.0% | +4875.0% |
LGND Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.0% | at low | -100.0% | at low | -9.8% | +5.8% |
| 5 y | 5-year | -100.0% | at low | -100.0% | at low | -9.8% | +26.3% |
| alltime | all time | -100.0% | at low | -100.0% | at low | -9.8% | +150.8% |
LGND Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $0.00(-100.0%) | $43.28M(-28.9%) |
| Mar 2025 | - | $18.80M(>+9900.0%) | $60.90M(+14.8%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(-100.0%) | $53.05M(-23.2%) |
| Sep 2024 | - | $24.48M(+38.9%) | $69.04M(+16.6%) |
| Jun 2024 | - | $17.62M(+60.9%) | $59.22M(+12.0%) |
| Mar 2024 | - | $10.95M(-31.5%) | $52.89M(+0.2%) |
| Dec 2023 | $52.79M(-24.7%) | $15.99M(+9.1%) | $52.79M(-22.3%) |
| Sep 2023 | - | $14.66M(+29.8%) | $67.93M(-0.4%) |
| Jun 2023 | - | $11.29M(+4.0%) | $68.19M(-1.2%) |
| Mar 2023 | - | $10.86M(-65.1%) | $68.99M(-1.5%) |
| Dec 2022 | $70.06M(+49.7%) | $31.13M(+108.7%) | $70.06M(+36.0%) |
| Sep 2022 | - | $14.92M(+23.4%) | $51.53M(+4.5%) |
| Jun 2022 | - | $12.09M(+1.4%) | $49.33M(-5.1%) |
| Mar 2022 | - | $11.93M(-5.3%) | $51.95M(-1.3%) |
| Dec 2021 | $46.79M(-27.4%) | $12.60M(-1.0%) | $52.64M(-24.9%) |
| Sep 2021 | - | $12.72M(-13.5%) | $70.13M(-3.2%) |
| Jun 2021 | - | $14.71M(+16.6%) | $72.43M(+6.8%) |
| Mar 2021 | - | $12.62M(-58.1%) | $67.79M(+5.2%) |
| Dec 2020 | $64.44M(+53.8%) | $30.08M(+100.3%) | $64.44M(+44.4%) |
| Sep 2020 | - | $15.02M(+49.2%) | $44.63M(+14.0%) |
| Jun 2020 | - | $10.07M(+8.7%) | $39.13M(-2.3%) |
| Mar 2020 | - | $9.26M(-9.9%) | $40.06M(-4.4%) |
| Dec 2019 | $41.88M(+11.0%) | $10.28M(+7.9%) | $41.88M(-2.1%) |
| Sep 2019 | - | $9.53M(-13.4%) | $42.77M(-0.3%) |
| Jun 2019 | - | $10.99M(-0.8%) | $42.88M(+4.1%) |
| Mar 2019 | - | $11.09M(-0.7%) | $41.18M(+9.1%) |
| Dec 2018 | $37.73M(+31.7%) | $11.16M(+15.9%) | $37.73M(+9.9%) |
| Sep 2018 | - | $9.63M(+3.6%) | $34.32M(+8.2%) |
| Jun 2018 | - | $9.29M(+21.6%) | $31.72M(+9.5%) |
| Mar 2018 | - | $7.64M(-1.4%) | $28.97M(+1.1%) |
| Dec 2017 | $28.65M(+7.6%) | $7.75M(+10.2%) | $28.65M(+4.1%) |
| Sep 2017 | - | $7.03M(+7.4%) | $27.53M(+2.7%) |
| Jun 2017 | - | $6.55M(-10.6%) | $26.80M(-1.2%) |
| Mar 2017 | - | $7.32M(+10.5%) | $27.12M(+1.9%) |
| Dec 2016 | $26.62M(+9.2%) | $6.63M(+5.1%) | $26.62M(+1.7%) |
| Sep 2016 | - | $6.30M(-8.1%) | $26.18M(+5.4%) |
| Jun 2016 | - | $6.86M(+0.6%) | $24.85M(-1.4%) |
| Mar 2016 | - | $6.83M(+10.3%) | $25.21M(+3.4%) |
| Dec 2015 | $24.38M(+8.0%) | $6.19M(+24.5%) | $24.38M(+2.5%) |
| Sep 2015 | - | $4.97M(-31.2%) | $23.79M(-6.9%) |
| Jun 2015 | - | $7.22M(+20.5%) | $25.56M(+8.4%) |
| Mar 2015 | - | $5.99M(+7.1%) | $23.57M(+4.1%) |
| Dec 2014 | $22.57M(+25.5%) | $5.60M(-17.0%) | $22.65M(+5.5%) |
| Sep 2014 | - | $6.74M(+28.7%) | $21.47M(+10.2%) |
| Jun 2014 | - | $5.24M(+3.3%) | $19.49M(+5.0%) |
| Mar 2014 | - | $5.07M(+14.8%) | $18.55M(+3.2%) |
| Dec 2013 | $17.98M(+11.6%) | $4.42M(-7.1%) | $17.98M(+0.8%) |
| Sep 2013 | - | $4.76M(+10.5%) | $17.85M(+2.1%) |
| Jun 2013 | - | $4.31M(-4.4%) | $17.47M(+2.1%) |
| Mar 2013 | - | $4.50M(+5.1%) | $17.11M(+6.2%) |
| Dec 2012 | $16.11M(+7.6%) | $4.28M(-2.2%) | $16.11M(+9.9%) |
| Sep 2012 | - | $4.38M(+11.2%) | $14.66M(+3.0%) |
| Jun 2012 | - | $3.94M(+12.5%) | $14.24M(+0.6%) |
| Mar 2012 | - | $3.50M(+23.7%) | $14.15M(+0.4%) |
| Dec 2011 | $14.98M(+16.7%) | $2.83M(-28.5%) | $14.09M(-4.3%) |
| Sep 2011 | - | $3.96M(+2.8%) | $14.73M(+6.4%) |
| Jun 2011 | - | $3.85M(+11.9%) | $13.84M(+4.3%) |
| Mar 2011 | - | $3.44M(-0.6%) | $13.28M(+3.1%) |
| Dec 2010 | $12.83M(-15.7%) | $3.47M(+12.8%) | $12.88M(+3.6%) |
| Sep 2010 | - | $3.07M(-6.6%) | $12.43M(+5.6%) |
| Jun 2010 | - | $3.29M(+7.9%) | $11.77M(+4.1%) |
| Mar 2010 | - | $3.05M(+0.9%) | $11.31M(-25.0%) |
| Dec 2009 | $15.21M | $3.02M(+25.1%) | $15.08M(-1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | $2.42M(-14.7%) | $15.27M(-18.7%) |
| Jun 2009 | - | $2.83M(-58.5%) | $18.78M(-8.4%) |
| Mar 2009 | - | $6.82M(+112.6%) | $20.50M(-11.2%) |
| Dec 2008 | $23.59M(+1.6%) | $3.21M(-45.9%) | $23.09M(-2.8%) |
| Sep 2008 | - | $5.93M(+30.3%) | $23.75M(+7.1%) |
| Jun 2008 | - | $4.55M(-51.6%) | $22.18M(-11.8%) |
| Mar 2008 | - | $9.40M(+142.8%) | $25.14M(+0.9%) |
| Dec 2007 | $23.21M(-79.5%) | $3.87M(-11.1%) | $24.91M(-24.6%) |
| Sep 2007 | - | $4.36M(-42.0%) | $33.02M(-45.4%) |
| Jun 2007 | - | $7.52M(-18.0%) | $60.53M(-31.8%) |
| Mar 2007 | - | $9.17M(-23.5%) | $88.72M(-21.3%) |
| Dec 2006 | $113.00M(+5.5%) | $11.98M(-62.4%) | $112.71M(-12.1%) |
| Sep 2006 | - | $31.86M(-10.8%) | $128.26M(+5.2%) |
| Jun 2006 | - | $35.71M(+7.7%) | $121.95M(+7.6%) |
| Mar 2006 | - | $33.16M(+20.4%) | $113.36M(+5.8%) |
| Dec 2005 | $107.16M(+11.8%) | $27.53M(+7.8%) | $107.16M(+3.9%) |
| Sep 2005 | - | $25.55M(-5.8%) | $103.13M(-0.3%) |
| Jun 2005 | - | $27.11M(+0.6%) | $103.39M(+2.0%) |
| Mar 2005 | - | $26.95M(+14.6%) | $101.39M(+5.8%) |
| Dec 2004 | $95.88M(+57.1%) | $23.51M(-8.9%) | $95.88M(+13.0%) |
| Sep 2004 | - | $25.81M(+2.8%) | $84.81M(+17.4%) |
| Jun 2004 | - | $25.12M(+17.2%) | $72.22M(+19.0%) |
| Mar 2004 | - | $21.44M(+72.2%) | $60.67M(+17.4%) |
| Dec 2003 | $61.02M(+46.4%) | $12.45M(-5.8%) | $51.66M(+31.7%) |
| Sep 2003 | - | $13.22M(-2.6%) | $39.21M(+6.7%) |
| Jun 2003 | - | $13.57M(+9.2%) | $36.76M(+9.8%) |
| Mar 2003 | - | $12.43M(>+9900.0%) | $33.47M(+9.0%) |
| Dec 2002 | $41.68M(+21.1%) | $0.00(-100.0%) | $30.70M(0.0%) |
| Sep 2002 | - | $10.77M(+4.7%) | $30.70M(+13.1%) |
| Jun 2002 | - | $10.28M(+6.4%) | $27.14M(+5.4%) |
| Mar 2002 | - | $9.66M(>+9900.0%) | $25.75M(-1.9%) |
| Dec 2001 | $34.43M(+0.9%) | $0.00(-100.0%) | $26.25M(0.0%) |
| Sep 2001 | - | $7.21M(-18.9%) | $26.25M(+37.8%) |
| Jun 2001 | - | $8.89M(-12.5%) | $19.04M(+87.5%) |
| Mar 2001 | - | $10.16M(>+9900.0%) | $10.16M(>+9900.0%) |
| Dec 2000 | $34.11M(+25.2%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1999 | $27.26M(+64.5%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1998 | $16.57M(+63.9%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 1998 | - | $0.00(0.0%) | $2.70M(-48.1%) |
| Jun 1998 | - | $0.00(0.0%) | $5.20M(-33.3%) |
| Mar 1998 | - | $0.00(-100.0%) | $7.80M(-22.8%) |
| Dec 1997 | $10.11M(-1.0%) | $2.70M(+8.0%) | $10.10M(-1.9%) |
| Sep 1997 | - | $2.50M(-3.8%) | $10.30M(+4.0%) |
| Jun 1997 | - | $2.60M(+13.0%) | $9.90M(0.0%) |
| Mar 1997 | - | $2.30M(-20.7%) | $9.90M(-2.9%) |
| Dec 1996 | $10.21M(>+9900.0%) | $2.90M(+38.1%) | $10.20M(+9.7%) |
| Sep 1996 | - | $2.10M(-19.2%) | $9.30M(-1.1%) |
| Jun 1996 | - | $2.60M(0.0%) | $9.40M(+38.2%) |
| Mar 1996 | - | $2.60M(+30.0%) | $6.80M(+15.3%) |
| Dec 1995 | $0.00(0.0%) | $2.00M(-9.1%) | $5.90M(0.0%) |
| Sep 1995 | - | $2.20M(+29.4%) | $5.90M(-16.9%) |
| Mar 1995 | - | $1.70M(-15.0%) | $7.10M(+1.4%) |
| Dec 1994 | $0.00(0.0%) | $2.00M(+17.6%) | $7.00M(+40.0%) |
| Sep 1994 | - | $1.70M(0.0%) | $5.00M(+51.5%) |
| Jun 1994 | - | $1.70M(+6.3%) | $3.30M(+106.3%) |
| Mar 1994 | - | $1.60M | $1.60M |
| Dec 1993 | $0.00(0.0%) | - | - |
| Dec 1992 | $0.00 | - | - |
FAQ
- What is Ligand Pharmaceuticals Incorporated annual SGA?
- What is the all time high annual SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated annual SGA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated quarterly SGA?
- What is the all time high quarterly SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated quarterly SGA year-on-year change?
- What is Ligand Pharmaceuticals Incorporated TTM SGA?
- What is the all time high TTM SGA for Ligand Pharmaceuticals Incorporated?
- What is Ligand Pharmaceuticals Incorporated TTM SGA year-on-year change?
What is Ligand Pharmaceuticals Incorporated annual SGA?
The current annual SGA of LGND is $0.00
What is the all time high annual SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high annual SGA is $113.00M
What is Ligand Pharmaceuticals Incorporated annual SGA year-on-year change?
Over the past year, LGND annual SGA has changed by -$52.79M (-100.00%)
What is Ligand Pharmaceuticals Incorporated quarterly SGA?
The current quarterly SGA of LGND is $0.00
What is the all time high quarterly SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high quarterly SGA is $35.71M
What is Ligand Pharmaceuticals Incorporated quarterly SGA year-on-year change?
Over the past year, LGND quarterly SGA has changed by -$17.62M (-100.00%)
What is Ligand Pharmaceuticals Incorporated TTM SGA?
The current TTM SGA of LGND is $1.95B
What is the all time high TTM SGA for Ligand Pharmaceuticals Incorporated?
Ligand Pharmaceuticals Incorporated all-time high TTM SGA is $2.16B
What is Ligand Pharmaceuticals Incorporated TTM SGA year-on-year change?
Over the past year, LGND TTM SGA has changed by +$1.89B (+3187.58%)